Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability

被引:36
作者
Spogli, Roberto [1 ]
Bastianini, Maria [1 ]
Ragonese, Francesco [2 ,3 ]
Iannitti, Rossana Giulietta [4 ]
Monarca, Lorenzo [2 ]
Bastioli, Federica [2 ]
Nakashidze, Irina [5 ]
Brecchia, Gabriele [6 ]
Menchetti, Laura [6 ]
Codini, Michela [7 ]
Arcuri, Cataldo [3 ]
Mancinelli, Loretta [2 ]
Fioretti, Bernard [2 ]
机构
[1] Univ Perugia, Prolabin & Tefarm, Spin Off Un, Via Acciaio 9, I-06134 Perugia, Italy
[2] Univ Perugia, Dept Chem Biol & Biotechnol, Via Elce Sotto 8, I-06123 Perugia, Italy
[3] Univ Perugia, Perugia Med Sch, Dept Expt Med, Piazza Lucio Severi 1, I-06132 Perugia, Italy
[4] S&R Farmaceut SpA Bastia Umbra, I-08063 Perugia, Italy
[5] Batumi Shota Rustaveli State Univ, Fac Nat Sci & Hlth Care, Dept Biol, Batumi 6010, Georgia
[6] Univ Perugia, Dept Vet Sci, Via San Costanzo 4, I-06126 Perugia, Italy
[7] Univ Perugia, Dept Pharmaceut Sci, Via A Fabretti 48, I-06123 Perugia, Italy
关键词
resveratrol; magnesium dihydroxide; solubility; bioavailability; dissolution rate; microparticles; TRANS-RESVERATROL; CLASSIFICATION; DISSOLUTION; SOLUBILITY; METABOLISM; ABSORPTION; DELIVERY; PROFILE; SYSTEM; IMPACT;
D O I
10.3390/nu10121925
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Resveratrol, because of its low solubility in water and its high membrane permeability, is collocated in the second class of the biopharmaceutical classification system, with limited bioavailability due to its dissolution rate. Solid dispersion of resveratrol supported on Magnesium DiHydroxide (Resv@MDH) was evaluated to improve solubility and increase bioavailability of resveratrol. Fluorimetric microscopy analysis displays three types of microparticles with similar size: Type 1 that emitted preferably fluorescence at 445 nm with bandwidth of 50 nm, type 2 that emitted preferably fluorescence at 605 nm with bandwidth of 70 nm and type 3 that is non-fluorescent. Micronized pure resveratrol displays only microparticles type 1 whereas type 3 are associated to pure magnesium dihydroxide. Dissolution test in simulated gastric environment resveratrol derived from Resv@MDH in comparison to resveratrol alone displayed better solubility. A 3-fold increase of resveratrol bioavailability was observed after oral administration of 50 mg/kg of resveratrol from Resv@MDH in rabbits. We hypothesize that type 2 microparticles represent magnesium dihydroxide microparticles with a resveratrol shell and that they are responsible for the improved resveratrol solubility and bioavailability of Resv@MDH.
引用
收藏
页数:10
相关论文
共 24 条
[1]   Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers [J].
Almeida, Luis ;
Vaz-da-Silva, Manuel ;
Falcao, Amilcar ;
Soares, Eva ;
Costa, Raquel ;
Loureiro, Ana I. ;
Fernandes-Lopes, Carlos ;
Rocha, Jose-Francisco ;
Nunes, Teresa ;
Wright, Lyndon ;
Soares-da-Silva, Patricio .
MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 :S7-S15
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   Optimization of trans-Resveratrol bioavailability for human therapy [J].
Amiot, Marie Josephe ;
Romier, Beatrice ;
Thi-Mai Anh Dao ;
Fanciullino, Raphaelle ;
Ciccolini, Joseph ;
Burcelin, Remy ;
Pechere, Laurent ;
Emond, Claude ;
Savouret, Jean-Francois ;
Seree, Eric .
BIOCHIMIE, 2013, 95 (06) :1233-1238
[4]   Administration of resveratrol: What formulation solutions to bioavailability limitations? [J].
Amri, A. ;
Chaumeil, J. C. ;
Sfar, S. ;
Charrueau, C. .
JOURNAL OF CONTROLLED RELEASE, 2012, 158 (02) :182-193
[5]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[6]   Determination of Quercetin and Resveratrol in Whole Blood-Implications for Bioavailability Studies [J].
Biasutto, Lucia ;
Marotta, Ester ;
Garbisa, Spiridione ;
Zoratti, Mario ;
Paradisi, Cristina .
MOLECULES, 2010, 15 (09) :6570-6579
[7]   Synthesis, characterisation and anion exchange properties of copper, magnesium, zinc and nickel hydroxy nitrates [J].
Biswick, T ;
Jones, W ;
Pacula, A ;
Serwicka, E .
JOURNAL OF SOLID STATE CHEMISTRY, 2006, 179 (01) :49-55
[8]   Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent [J].
Boocock, David J. ;
Faust, Guy E. S. ;
Patel, Ketan R. ;
Schinas, Anna M. ;
Brown, Victoria A. ;
Ducharme, Murray P. ;
Booth, Tristan D. ;
Crowell, James A. ;
Perloff, Marjorie ;
Gescher, Andreas J. ;
Steward, William P. ;
Brenner, Dean E. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (06) :1246-1252
[9]   Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability? [J].
Brouwers, Joachim ;
Brewster, Marcus E. ;
Augustijns, Patrick .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (08) :2549-2572
[10]   The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol [J].
Das, Surajit ;
Lin, Hai-Shu ;
Ho, Paul C. ;
Ng, Ka-Yun .
PHARMACEUTICAL RESEARCH, 2008, 25 (11) :2593-2600